NCT00462124View on ClinicalTrials.gov

Evaluation of the Safety and Efficacy of the BioProtect Balloon in Prostate Cancer Subjects Undergoing Radiotherapy

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

May 31, 2009

Conditions
Prostate Cancer
Interventions
DEVICE

Absorbable perirectal spacer

biodegradable balloon implant to increase the distance between prostate and anterior rectal wall

Trial Locations (1)

Unknown

Ichilov Medical Center, Tel Aviv

Sponsors

Lead Sponsor

BioProtect
All Listed Sponsors
lead

BioProtect

INDUSTRY